3B Blackbio Dx logo

3B Blackbio Dx financials and balance sheet

NSE: 3BBLACKBIOBSE: 532067Healthcare ServicesSmall Cap

Last close ₹1,334.40down ₹14.90 (1.10%)BSE ₹1,332.95

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,349.30.

52-week range of BSE trades to 23 Oct 2026
₹1,083.50Low, 2 Jun 2026₹1,750.00High, 19 Jan 2026
Market cap
₹1,145 Cr1,399th largest listed
P/E
20.6
P/B
3.5
Dividend yield
0.37%
ROE
18.7%
ROCE
14.1%
Debt to equity
0.01
Volume, NSE
12,68247.3% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.3B Blackbio Dx annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹227 Cr, year to Mar 2021

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue142
  2. Materials and goods−36
  3. Employee costs−24
  4. Other expenses−25
  5. Operating profit57
  6. Depreciation−5.1
  7. Other income+26
  8. One-off items0.0
  9. Finance costs−0.2
  10. Profit before tax77
  11. Tax−17
  12. Net profit60

What the company owns

  • Plant, investments and other assets₹209 Cr
  • Cash and bank₹101 Cr
  • Receivables₹50 Cr
  • Inventory₹18 Cr

What pays for it: net worth and liabilities

  • Net worth₹332 Cr
  • Other liabilities₹36 Cr
  • Owed to suppliers₹7 Cr
  • Borrowings₹3 Cr

3B Blackbio Dx business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Consolidated, ₹ crore, as the company reports them.3B Blackbio Dx segment results by quarter

Revenue by segment

₹142 CrTotal
  • Diagnostic Kits₹131 Cr92.4% of total
  • Agrochemicals₹11 Cr7.6% of total

Profit by segment

  • Diagnostic Kits₹77.1 Cr99.8% of total
  • Agrochemicals₹0.1 Cr0.2% of total

Segment results by year

Consolidated, ₹ crore, years to March.

  • Diagnostic Kits

    Revenue, ₹ crore
    Profit, ₹ crore
  • Agrochemicals

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses243123582637596142
Company revenue, as in its results232922781627496142
Revenue111621767516184131
Revenue growth–41.3%1,275.7%−69.2%−24.4%20.5%38.5%55.6%
Profit791504235456477
Profit growth–45.0%1,488.9%−71.7%−17.7%28.4%43.2%20.0%
Margin58.3%59.8%69.1%63.4%69.1%73.7%76.2%58.8%
Return on capital77.9%55.3%116.0%27.9%19.9%21.9%26.1%25.1%
Assets1120169164191224269351
Liabilities33401216192244
Capital employed817129152175205246306
Revenue1315181612141211
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Consolidated, ₹ crore, years to March.3B Blackbio Dx quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 27 MayMar 2020Filed 27 JunMar 2021Filed 24 JunMar 2022Filed 7 JunMar 2023Filed 29 MayMar 2024Filed 3 AugMar 2025Filed 12 JunMar 2026Filed 29 May
Revenue from operations1623232922781627496142
14181620774433414685
Materials and goods bought8131113523218222636
Employee costs2–335457724
Other expenses3–3321810131325
Operating profit before depreciation35791503729335057
Operating margin15.9%23.2%31.0%32.3%66.1%46.0%47.1%44.5%51.9%40.0%
Materials, % of revenue51.8%–46.5%45.9%22.7%39.2%29.0%29.5%26.6%25.3%
Employee costs, % of revenue12.5%–10.9%9.9%2.1%4.4%8.1%8.8%7.6%16.9%
Other expenses, % of revenue19.8%–11.6%11.9%9.0%10.4%15.8%17.3%13.9%17.8%
Depreciation and amortisation0011111115
Operating profit after depreciation25791493628324952
Other income0012377131526
Finance costs1100000000
Profit before one-off items and tax157101524335446477
One-off items0000000000
Profit before tax157101524335446477
012238119121617
13581143226324860
Other comprehensive income––00000000
Total comprehensive income––581143226324860
Net margin7.0%14.6%22.5%26.6%50.2%39.9%41.9%43.3%49.4%42.2%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 27 MayMar 2020Filed 27 JunMar 2021Filed 24 JunMar 2022Filed 7 JunMar 2023Filed 29 MayMar 2024Filed 3 AugMar 2025Filed 12 JunMar 2026Filed 29 May
2334148172196225271332
2332132153171223268324
Share capital67777999
Reserves1625125146164214260316
Belonging to outside owners of subsidiaries02161925237
64232103
108431714181937
322345610
Total assets3645194192214248296378
4675111100125164185
323911882114123132193
Net debt3−6−33−26−57−61−69−98
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 24 JunMar 2022Filed 7 JunMar 2023Filed 29 MayMar 2024Filed 3 AugMar 2025Filed 12 JunMar 2026Filed 29 May
983723274352
1354832446471
−174−5−2−1−11
Receivables−5333−2−10−2−19
Inventories−1−3−100−10
Payables36−27−28118
Other working capital000000
Tax paid−38−11−9−11−15−16
Interest paid000000
Capital spending0200126
Free cash flow983523274227
−70−2812−20−34−24
−2−15−5−4−3−1
Dividends paid0154233
Shares bought back000000
Shares issued000000
Net change in cash26−6303628
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.3B Blackbio Dx dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 27 MayMar 2020Filed 27 JunMar 2021Filed 24 JunMar 2022Filed 7 JunMar 2023Filed 29 MayMar 2024Filed 3 AugMar 2025Filed 12 JunMar 2026Filed 29 May
Earnings per share₹1.77₹5.35₹8.18₹10.22₹151.68₹42.89₹34.55₹37.46₹55.66₹69.94
Diluted earnings per share₹1.77₹5.35₹8.18₹10.22₹151.68₹42.89₹34.55₹37.46₹55.66₹69.94
Dividend per share₹0.30₹0.50₹0.50₹0.70₹9.00₹2.50₹2.50₹3.00₹4.00₹5.00
Book value per share––₹35.12₹42.77₹175.88₹203.81₹228.06₹260.38₹313.27₹378.58
Dividend payout17.0%9.4%6.4%7.7%6.8%6.7%8.3%7.9%7.2%7.3%
Shareholder yield––––0.0%6.0%1.4%0.4%0.2%0.4%
Market cap at the year end (₹ crore)228648542142563125781,388966

Ratios

Consolidated, years to March.3B Blackbio Dx PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 27 MayMar 2020Filed 27 JunMar 2021Filed 24 JunMar 2022Filed 7 JunMar 2023Filed 29 MayMar 2024Filed 3 AugMar 2025Filed 12 JunMar 2026Filed 29 May
Revenue growth–44.9%−0.6%24.0%685.3%−64.4%−23.3%19.9%30.1%47.1%
Operating profit growth–111.7%33.0%29.1%1,509.7%−75.3%−21.4%13.2%51.9%13.3%
Net profit growth–202.7%53.0%46.7%1,381.3%−71.7%−19.4%23.8%48.6%25.7%
Earnings per share growth–202.3%52.9%24.9%1,384.1%−71.7%−19.4%8.4%48.6%25.7%
––22.3%24.9%121.6%19.8%14.0%16.6%19.4%19.8%
–––2.6 pts96.7 pts−101.8 pts−5.8 pts2.6 pts2.8 pts0.4 pts
From the net margin–––2.1 pts21.6 pts−25.0 pts1.0 pts2.9 pts2.0 pts−3.2 pts
From asset turnover–––2.7 pts77.9 pts−75.4 pts−5.6 pts0.9 pts2.0 pts3.0 pts
From borrowing–––−2.2 pts−2.9 pts−1.5 pts−1.1 pts−1.1 pts−1.2 pts0.5 pts
Return on capital employed––23.1%23.2%99.4%20.9%14.3%14.1%18.1%15.4%
Cash conversion––––85.6%115.9%88.3%84.0%90.9%87.6%
Interest cover2.16.814.426.3654.3342.4142.5256.6451.8217.8
Debt to equity––0.270.100.010.010.010.000.000.01
Receivable days––29025256136200178138129
Inventory days––1681123486164141124187
Payable days––13293214169662870
Cash conversion cycle, days––32627170181296253235245
Working capital days––35130167169248216169143
Asset turnover––0.640.711.900.420.300.320.350.42
Assets per rupee of net worth––1.611.491.451.351.251.171.111.14
Sales per rupee of plant––6.267.7145.3712.207.9410.0213.365.14
Capital spending to depreciation––––0.003.370.000.000.834.98
Plant being built, % of plant in use––2.7%5.3%2.7%1.7%1.2%–––
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
17.4%
Cash from operations against operating profit
92.4%
Measure10 years5 years3 years
Revenue growth, yearly rate–−8.9%31.9%
Profit growth, yearly rate–−10.1%37.2%
Return on equity, average–17.9%18.6%
Return on capital employed, average–16.6%15.9%
Operating margin, average39.8%45.9%45.5%
Net margin, average33.8%43.4%45.0%
Asset turnover, average–0.360.37
Cash conversion cycle, days, average–242244
Interest cover, average211.5282.2308.8
Debt to equity, average–0.010.00

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations18312352
Cash from investing−94−78−24
Cash from financing−27−7−1
Capital spending292626
Dividends paid2883
Shares bought back000
Shares issued for cash000
Borrowings raised–33
Borrowings repaid110

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––656586
Altman Z-scorePublished threshold 1.81––4.796.107.9710.3112.7920.0936.3715.20
Beneish M-scorePublished threshold −1.78––––4.79−1.58−2.69−2.74––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––72.6712.09−4.4711.0214.049.22
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.920.970.880.88
Receivables growth less revenue growthOur threshold 0 percentage points–––−16.23−610.7250.6136.54−13.08−29.39−9.96
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−40.90−269.2091.2151.54−17.15−13.6870.41
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––2.2916.61−35.20−3.544.871.583.86
Assets under construction, years of additionsOur threshold 2 years of additions–––0.350.070.050.05–––
Effective tax ratePublished threshold 17.16 per cent18.9724.1424.6023.5225.1025.5026.5427.5925.4822.14
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––1.071.223.142.381.15
A threshold marked as ours has no published figure; it is the line we read the check against.